Depression study for older people who drive
Treatments studied
Part of Mental health clinical trials.
This study looks at how depression relates to the brain by using blood tests and either a spinal fluid test or brain scans. It may help researchers better understand depression in older drivers and how to measure it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years old or older
- You drive at least once per week
- You have a valid driver’s license
- You can and are willing to have a blood draw
- You are willing to have either a lumbar puncture (spinal fluid test) or a PET scan (brain scan)
- You speak English
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses two special brain scans (DPA-714 and FDG PET/MRI) to look at inflammation and brain activity in people with first-episode or recurrent depression, and in healthy volunteers. It aims to find brain differences that could lead to better treatments.
This Phase 1 study uses a PET brain scan tracer to see how a specific brain target (PDE4B) is involved in major depressive disorder (MDD). It’s mainly testing whether the imaging approach works and what it shows in people with depression who meet specific safety and medication rules.
This study uses a special PET scan to look at MAO-A, a brain chemical linked to depression. It may help doctors better understand and diagnose depression.
This study uses brain scans (MRI) to understand how people with depression process rewards, aiming to identify different depression subtypes. You may join if you have depression or if you are a healthy volunteer.
This Phase 1 study uses a PET brain scan to look at inflammation-related activity (cyclooxygenase) in people with major depressive disorder (MDD). It may help researchers better understand how depression is connected to inflammation in the brain.
This study uses brain imaging to understand changes in the brain during normal aging and early Alzheimer’s disease (AD). It may help researchers spot early brain changes and evaluate how well imaging measures those changes.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.